Biotech company Biocon stated that its division 'Clinigene International' has signed a deal with US-based Spaulding Clinical Research to mutually offer clinical research solutions to both pharmaceutical plus biotechnology companies.
This affiliation establishes a cost-effective international footprint for clinical pharmacology services, offering up a chance for both organizations to take on pharmaceutical customers with regard to strategy.
Clinigene Chief Operating Officer Abhijit Barve stated: "Pharmaceutical clients globally are increasingly seeking strategies to expedite their early clinical development, streamlining processes while maintaining high quality.
No comments:
Post a Comment